These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22944746)

  • 1. The accomplishments of the global initiative VISION 2020: The Right to Sight and the focus for the next 8 years of the campaign.
    Ackland P
    Indian J Ophthalmol; 2012; 60(5):380-6. PubMed ID: 22944746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing advocacy for eye care at national levels: what steps to take for the next decade?
    Rabiu MM; Al Rajhi A; Qureshi MB; Gersbeck J
    Middle East Afr J Ophthalmol; 2012 Jan; 19(1):75-82. PubMed ID: 22346118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.
    ;
    Lancet Glob Health; 2021 Feb; 9(2):e144-e160. PubMed ID: 33275949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty Year Projected Magnitude (to 2050) of Near and Distance Vision Impairment and the Economic Impact if Existing Solutions are Implemented Globally.
    Bastawrous A; Suni AV
    Ophthalmic Epidemiol; 2020 Apr; 27(2):115-120. PubMed ID: 31810404
    [No Abstract]   [Full Text] [Related]  

  • 5. Vision 2020: where are we?
    Bourne RRA
    Curr Opin Ophthalmol; 2020 Mar; 31(2):81-84. PubMed ID: 31904597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blindness prevention programmes: past, present, and future.
    Resnikoff S; Pararajasegaram R
    Bull World Health Organ; 2001; 79(3):222-6. PubMed ID: 11285666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.
    ;
    Lancet Glob Health; 2021 Feb; 9(2):e130-e143. PubMed ID: 33275950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019.
    Xu T; Wang B; Liu H; Wang H; Yin P; Dong W; Li J; Wang YX; Yusufu M; Briant P; Reinig N; Ashbaugh C; Adelson J; Vos T; Bourne R; Wang N; Zhou M
    Lancet Public Health; 2020 Dec; 5(12):e682-e691. PubMed ID: 33271081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Millennium development goals and eye health.
    Faal HB
    Indian J Ophthalmol; 2012; 60(5):411-5. PubMed ID: 22944751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of cataract blindness and Vision 2020: the right to sight initiative in India.
    Murthy G; Gupta SK; John N; Vashist P
    Indian J Ophthalmol; 2008; 56(6):489-94. PubMed ID: 18974520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking forward to 20/20: a focus on the epidemiology of eye diseases.
    West SK
    Epidemiol Rev; 2000; 22(1):64-70. PubMed ID: 10939008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Vision Care: Issues and Approaches.
    Khanna RC; Marmamula S; Rao GN
    Annu Rev Vis Sci; 2017 Sep; 3():53-68. PubMed ID: 28937949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnitude and cost of global blindness: an increasing problem that can be alleviated.
    Frick KD; Foster A
    Am J Ophthalmol; 2003 Apr; 135(4):471-6. PubMed ID: 12654362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude and causes of blindness and low vision in Anambra State of Nigeria (results of 1992 point prevalence survey).
    Ezepue UF
    Public Health; 1997 Sep; 111(5):305-9. PubMed ID: 9308379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating synergies for health systems strengthening through partnerships in Pakistan--a case study of the national eye health programme.
    Khan AA; Khan NU; Bile KM; Awan H
    East Mediterr Health J; 2010; 16 Suppl():S61-8. PubMed ID: 21495590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volunteer-based vision nongovernmental organizations and VISION 2020.
    Pearce MG
    Optometry; 2008 Aug; 79(8):464-71. PubMed ID: 18656085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of avoidable blindness due to cataract: where do we prioritize and how should we monitor this decade?
    Murthy G; John N; Shamanna BR; Pant HB
    Indian J Ophthalmol; 2012; 60(5):438-45. PubMed ID: 22944756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey.
    Abdull MM; Sivasubramaniam S; Murthy GV; Gilbert C; Abubakar T; Ezelum C; Rabiu MM;
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4114-20. PubMed ID: 19387071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative assessment of avoidable blindness and visual impairment in seven Latin American countries: prevalence, coverage, and inequality.
    Silva JC; Mújica OJ; Vega E; Barcelo A; Lansingh VC; McLeod J; Limburg H
    Rev Panam Salud Publica; 2015 Jan; 37(1):13-20. PubMed ID: 25791184
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.